Viva Biotech Holdings (1873.HK) HKSE
Currency In HKD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 3.95B |
| Enterprise Value | 4.17B |
| P/E Ratio | 9.79 |
| PEG Ratio | 0.29 |
| Price/Sales Ratio | 1.16 |
| Price/Book Ratio | 0.6 |
| Enterprise/Revenue | 1.29 |
| Enterprise/EBITDA | 5.8 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
Profitability
| Profit Margin | 0.13 |
| Operating Margin | 0.11 |
AD
Management Effectiveness
| Return On Assets | 0.03 |
| Return On Equity | 0.06 |
Income Statement
| Revenue | 1.73B |
| Revenue/Share | 0.69 |
| Gross Profit | 655.56M |
| EBITDA | 385.38M |
| Net Income | 219.76M |
| Diluted EPS | 0.09 |
Balance Sheet
| Total Cash | 1.13B |
| Total Cash/Share | 0.45 |
| Total Debt | 1.33B |
| Total Debt/Equity | 0.33 |
| Current Ratio | 1.5 |
| Book Value Per Share | 1.6 |
Price History
| 52-Week Change | -27.27 |
| 52-Week High | 3.27 |
| 52-Week Low | 1.05 |
| Moving Average 50 Days | 1.51 |
| Moving Average 200 Days | 2.06 |
Statistics
| Average Volume | 5.44M |
| Shares Outstanding | 2.08B |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
